[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$flmTeVh2vOCSLkesAF_RTxJYAhfeVC8Ei1WbbnsOf2VM":8,"$fBJaouhIW5a4-OksOhID1XCCwKFd0cQsV7sN7TKrn66M":55,"$f5hZaULk6dbgUu8LgzRVQ1DHNsuL4MzJvesglbCB45hs":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67653,867514,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//nqL2t0ch6TCNrtDdNzheeMcnEUqvRosA.png","关明","上海高博肿瘤医院","肿瘤科","副主任医师",77,0,"肺癌EGFR L858R突变用药指南：关键用药细节全解析","","https://ystcdn.venuertc.com/venue/AI/68e5e40b-544b-4393-9c27-bf09817842c2.jpg","\u003Cdiv class=\"smartmed-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"smartmed-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌EGFR L858R突变用药指南：关键用药细节全解析\u003C/h2>\n  \n  \u003Cdiv class=\"smartmed-block smartmed-intro\">\n    \u003Cp>日常用药过程中，EGFR抑制剂是一类被广泛关注的靶向药物。针对EGFR L858R突变，用药方案更为特殊，涉及多种药品（如厄洛替尼、吉非替尼、阿法替尼、奥希替尼等），不同的剂型、服药法、注意事项和储存技巧都值得逐条细究。本指南总结了8个你不能忽视的药品使用细节，从用法、用量，到安全细节与相互作用，帮你真正做好科学、安心的用药。\u003C/p>\n  \u003C/div>\n\n  \u003C!-- 01 EGFR L858R突变靶向药有哪些成分？ -->\n  \u003Csection class=\"smartmed-section smartmed-bg-1\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1️⃣ EGFR L858R突变相关靶向药：主要成分及类型\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>常见代表：\u003C/strong>厄洛替尼（Erlotinib）、吉非替尼（Gefitinib）、阿法替尼（Afatinib）、奥希替尼（Osimertinib）。\u003C/li>\n      \u003Cli>\u003Cstrong>药品剂型：\u003C/strong>通常为片剂或胶囊，便于口服。\u003C/li>\n      \u003Cli>\u003Cstrong>成分说明：\u003C/strong>\n        \u003Cul>\n          \u003Cli>厄洛替尼和吉非替尼属于第一代EGFR酪氨酸激酶抑制剂（TKI）。\u003C/li>\n          \u003Cli>阿法替尼是第二代EGFR-TKI。\u003C/li>\n          \u003Cli>奥希替尼为第三代EGFR-TKI，适用于部分耐药情况。\u003C/li>\n        \u003C/ul>\n      \u003C/li>\n      \u003Cli>\u003Cstrong>规格举例：\u003C/strong>常见厄洛替尼片剂100mg、150mg；吉非替尼片剂250mg；阿法替尼片剂20mg、30mg、40mg；奥希替尼片剂40mg、80mg等。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip\">\u003Cspan class=\"smartmed-emoji\">💡\u003C/span>选择剂型和规格，应根据医生建议与手中药品说明书为准。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药品作用机制（不涉及疾病过程） -->\n  \u003Csection class=\"smartmed-section smartmed-bg-2\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2️⃣ EGFR L858R靶向药的作用机制简述\u003C/h2>\n    \u003Cul>\n      \u003Cli>这些药物通过\u003Cstrong>选择性抑制EGFR酪氨酸激酶活性\u003C/strong>，阻断信号通路，干扰细胞的异常增殖。\u003C/li>\n      \u003Cli>不同代际药物对突变型EGFR的亲和力和耐药性克服能力有区别。例如，奥希替尼对T790M耐药突变有更强识别能力。\u003C/li>\n      \u003Cli>不会直接影响正常细胞的生理信号传导，但因作用于特定生长因子，偶有干扰皮肤、肠道等正常细胞。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip\">\u003Cspan class=\"smartmed-emoji\">🔬\u003C/span>原理很抽象，可以简单理解为“智能锁定”异常酶活性的“钥匙”。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 如何正确服用EGFR TKI药物 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-3\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3️⃣ 用法用量：EGFR抑制剂的正确服用方式\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>厄洛替尼：\u003C/strong>必须空腹服用（餐前1小时或餐后2小时），用足量清水吞服，不可嚼碎。\u003C/li>\n      \u003Cli>\u003Cstrong>吉非替尼：\u003C/strong>每日一次，可餐前或餐后服用，餐食影响较小，但建议每日固定时间。\u003C/li>\n      \u003Cli>\u003Cstrong>阿法替尼：\u003C/strong>空腹服用，餐前至少1小时或餐后2小时，需整片吞服。\u003C/li>\n      \u003Cli>\u003Cstrong>奥希替尼：\u003C/strong>与食物同服或空腹皆可，整片吞下。\u003C/li>\n      \u003Cli>\u003Cstrong>正确做法：\u003C/strong>服药时尽量用200ml-250ml温水送服，不建议与果汁、牛奶等混合服用。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip\">\u003Cspan class=\"smartmed-emoji\">⏰\u003C/span>有条件的话，设立手机提醒，确保每天同一时间服药。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 剂量调整与特殊人群用药 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-4\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4️⃣ 特殊人群剂量调整：老年、肝肾损伤、儿童、孕产妇\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>老年人：\u003C/strong>一般不需常规调整，但如果出现不耐受或明显不良反应，可根据医生指示减量。\u003C/li>\n      \u003Cli>\u003Cstrong>肝肾功能减退：\u003C/strong>中重度肝损伤患者服用厄洛替尼或阿法替尼时需谨慎，必要时减量或停药（详见说明书）。\u003C/li>\n      \u003Cli>\u003Cstrong>儿童：\u003C/strong>这些药品多无儿童适应症，18岁以下用药风险较高，禁止自行给药。\u003C/li>\n      \u003Cli>\u003Cstrong>孕妇与哺乳期：\u003C/strong>动物研究显示有致畸风险，建议孕期及哺乳期慎用或禁用，务必咨询医生。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip smartmed-att\">\u003Cspan class=\"smartmed-emoji\">⚠️\u003C/span>遇到特殊人群切勿擅自加减剂量，应遵医嘱操作！\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 常见药物相互作用 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-5\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5️⃣ 药物相互作用：这几类药别一起用！\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>抗酸药：\u003C/strong>如质子泵抑制剂、H2受体拮抗剂、铝镁制酸剂，会降低厄洛替尼、吉非替尼的血药浓度，应避免同服。\u003C/li>\n      \u003Cli>\u003Cstrong>CYP酶抑制剂/诱导剂：\u003C/strong>酮康唑、利福平、卡马西平等会影响EGFR-TKI的代谢，导致药效减弱或毒性增加。\u003C/li>\n      \u003Cli>\u003Cstrong>草药制剂：\u003C/strong>如圣约翰草，可显著影响药物代谢。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip\">\u003Cspan class=\"smartmed-emoji\">🚫\u003C/span>如必须同时使用上述药品，至少间隔4小时以上，最好由医生调整用药顺序。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 EGFR靶向药常见不良反应及处理思路 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-6\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6️⃣ 常见不良反应：别怕，关键是早识别早处理\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>皮肤反应：\u003C/strong>以皮疹、干燥、瘙痒为主，发生率约60-90%（Yang et al., 2017）；一般不需停药，外用润肤剂或短期抗生素可缓解。\u003C/li>\n      \u003Cli>\u003Cstrong>腹泻：\u003C/strong>尤其阿法替尼，偶可较重；需补充水分、必要时口服止泻药。\u003C/li>\n      \u003Cli>\u003Cstrong>肝功能异常：\u003C/strong>定期肝功能检查，如ALT、AST升高，及时咨询医生。\u003C/li>\n      \u003Cli>\u003Cstrong>指甲、口腔等并发症：\u003C/strong>如指甲炎、口腔溃疡，建议加强日常护理。\u003C/li>\n      \u003Cli>\u003Cstrong>其他罕见：\u003C/strong>呼吸异常、间质性肺炎等，一发现异常呼吸或持续高热即停药就医。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip smartmed-att\">\u003Cspan class=\"smartmed-emoji\">🩹\u003C/span>若遇轻度皮疹、口腔不适，可用温热水漱口、保护皮肤；严重或者持续不适应尽快就医。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 辅助及联合用药举例（用药案例展示） -->\n  \u003Csection class=\"smartmed-section smartmed-bg-7\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7️⃣ 真实用药案例分享：剂量调整、辅助用药经验\u003C/h2>\n    \u003Cul>\n      \u003Cli>一位71岁女性患者，在EGFR L858R突变确诊后，使用了含铂化疗联合厄洛替尼方案，治疗过程中辅助了止吐药、胃黏膜保护剂和营养支持，未出现严重并发症。\u003C/li>\n      \u003Cli>临床时常配合保肝药物、胃黏膜保护剂，以提高耐受性与顺利完成疗程。\u003C/li>\n      \u003Cli>用药调整要点：如遇不良反应，医生可能会建议减量、短期中断，再重新评估继续使用。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip\">\u003Cspan class=\"smartmed-emoji\">👩‍⚕️\u003C/span>特别提醒，联合用药时每种药品均须严格遵守用药规范，不可任意停换。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存方法与漏服补救措施 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-8\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8️⃣ 储存与漏服处理：让药物始终保持最佳活性\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>储存温度：\u003C/strong>绝大多数EGFR-TKI需存放于干燥阴凉处，25℃以下为佳，避免潮湿与强光直射。\u003C/li>\n      \u003Cli>\u003Cstrong>开封保存：\u003C/strong>已开瓶药物建议一个月内用完，如未注明有效期，则遵守外包装说明。\u003C/li>\n      \u003Cli>\u003Cstrong>过期处理：\u003C/strong>过期药不可继续服用，应交由合规药品回收点处理。\u003C/li>\n      \u003Cli>\u003Cstrong>漏服补救：\u003C/strong>若发现漏服，若时间间隔较短（6小时以内）可尽快补服；如接近下次服药，跳过漏服直接按原时间服用，不可一次服两倍剂量。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"smartmed-tip\">\u003Cspan class=\"smartmed-emoji\">🔄\u003C/span>每次服药前请检查药品包装与有效期，切莫误服变质药！\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 内容汇总与用药安全小结 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-summary\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结：安全用药的两大关键\u003C/h2>\n    \u003Cp>\n      EGFR L858R突变相关靶向药物，优势在于作用精准、口服方便，但在用法用量、药物相互作用与不良反应防控等方面有严格要求。最重要的，一是每一剂药都要严格按说明书服用，二是所有问题及时和医生沟通，切勿自行增减用量或随意停药。理智、安全的用药，才能真正发挥药品最大效益。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 10 参考文献 -->\n  \u003Csection class=\"smartmed-section smartmed-bg-ref\">\n    \u003Ch2 class=\"smartmed-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col>\n      \u003Cli>Yang, J.C.H., Kim, S.W., Kim, D.W., et al. (2017). Osimertinib in Pre-Treated T790M-Positive Advanced Non-Small-Cell Lung Cancer: AURA Study Results. \u003Cem>Lancet Oncology\u003C/em>, 18(10), 1378-1391.\u003C/li>\n      \u003Cli>Keating, G.M. (2015). Afatinib: A Review in Metastatic NSCLC with EGFR Mutation. \u003Cem>Drugs\u003C/em>, 75(12), 1335-1346.\u003C/li>\n      \u003Cli>Mok, T.S., Wu, Y.L., Thongprasert, S., et al. (2009). Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma. \u003Cem>New England Journal of Medicine\u003C/em>, 361, 947-957.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.smartmed-material-container {\n  font-family: \"Helvetica Neue\", Helvetica, Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  color: #333;\n  background: #fafbfc;\n  max-width: 740px;\n  margin: 28px auto;\n  border-radius: 14px;\n  box-shadow: 0 4px 20px 0 #e8ebef;\n  padding: 40px 32px 32px 32px;\n  font-size: 16px;\n  line-height: 1.85;\n}\n\n.smartmed-title {\n  text-align: center;\n  font-size: 2.3em;\n  color: #1c344a;\n  font-weight: bold;\n  margin: 0 0 30px 0;\n  letter-spacing: 2px;\n}\n\n.smartmed-block {\n  margin-bottom: 32px;\n  padding: 22px 24px;\n  border-radius: 10px;\n  background: #f5f9fd;\n}\n\n.smartmed-intro {\n  font-size: 1.13em;\n  background: linear-gradient(110deg, #f1f6fa 70%, #e3ecf7 100%);\n  border-left: 7px solid #41a0e2;\n}\n\n.smartmed-section {\n  margin-bottom: 32px;\n  padding: 26px 26px 18px 26px;\n  border-radius: 12px;\n  background-repeat: no-repeat;\n  background-size: 44px 44px;\n  background-position: top right 22px;\n  border: 1.4px solid #e4ecf8;\n  box-shadow: 0 2px 10px 0 #f3f7fa;\n}\n\n.smartmed-bg-1 { background: linear-gradient(101deg,#ebf5fc 88%,#ecfeed 100%); }\n.smartmed-bg-2 { background: linear-gradient(105deg,#f4f7fc 78%,#eaf2fa 100%); }\n.smartmed-bg-3 { background: linear-gradient(120deg,#edf7fa 93%,#faf4eb 100%); }\n.smartmed-bg-4 { background: linear-gradient(120deg,#f1fbf8 88%,#eef2fd 100%);}\n.smartmed-bg-5 { background: linear-gradient(115deg,#f8f9fa 80%,#eaf8f1 100%);}\n.smartmed-bg-6 { background: linear-gradient(110deg,#fbf2e8 87%,#e8edfc 100%);}\n.smartmed-bg-7 { background: linear-gradient(109deg,#f8f5fb 73%,#e3f1ff 100%);}\n.smartmed-bg-8 { background: linear-gradient(100deg,#fafbf1 70%,#e6f1f5 100%);}\n.smartmed-bg-summary { background: linear-gradient(105deg,#f9faf3 90%,#ebf6ef 100%);}\n.smartmed-bg-ref { background: linear-gradient(120deg,#f7fafe 93%,#e3f2fa 100%);}\n.smartmed-h2 {\n  font-size: 1.36em;\n  margin: 0 0 16px 0;\n  color: #217aa3;\n  font-weight: 600;\n  letter-spacing: 0.03em;\n  background: rgba(216,239,255, 0.30);\n  border-left: 5px solid #41a0e2;\n  padding: 6px 0 6px 18px;\n  border-radius: 7px;\n}\n.smartmed-section ul, .smartmed-section ol {\n  margin: 0 0 10px 28px;\n  padding: 0 0 0 15px;\n}\n.smartmed-section li {\n  margin-bottom: 5px;\n}\n.smartmed-section strong {\n  color: #23527c;\n}\n.smartmed-tip {\n  background: #f2f7fa;\n  color: #2e4665;\n  padding: 9px 14px;\n  font-size: 1em;\n  border-radius: 8px;\n  margin-top: 7px;\n  margin-bottom: 0;\n  display: flex;\n  align-items: center;\n  column-gap: 8px;\n}\n.smartmed-tip.smartmed-att {\n  background: linear-gradient(90deg,#fde7e4 60%,#f5f1ec 100%);\n  color: #a13b3b;\n}\n.smartmed-emoji {\n  font-size: 1.24em !important;\n  margin-right: 8px;\n  flex-shrink: 0;\n}\n.smartmed-section em {\n  color: #376fa4;\n  font-style: italic;\n}\n.smartmed-section p {\n  margin: 0 0 10px 0;\n}\n.smartmed-bg-ref ol {\n  margin-left: 20px;\n}\n@media (max-width: 800px) {\n  .smartmed-material-container {\n    padding: 16px 2.5vw 22px 2.5vw;\n    max-width: 96vw;\n    font-size: 15px;\n  }\n  .smartmed-h2 {\n    font-size: 1.09em;\n    padding: 6px 0 6px 12px;\n  }\n  .smartmed-section {\n    padding: 14px 7px 11px 12px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"smartmed-material-container\">\n  \u003Ch2 id=\"material_title\" class=\"smartmed-title\" style=\"co",524,"2025-10-10 17:13:14","EGFR L858R突变, 肺癌用药, 靶向药物, 药物相互作用, 不良反应","深入了解EGFR L858R突变相关的靶向药物使用指南，明确用法、用量与不良反应，确保安全有效用药，适合肺癌患者及医务工作者参考。","2025-10-29 06:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]